Research
We emphasize the continuation and advancement of care. For appropriate patients, enrollment in an active clinical trial is one option discussed alongside standard treatments after a complete diagnostic workup.
Many patients ask about clinical trials as a next step. We share that interest. Trials are how the field moves forward, and they sometimes offer access to techniques that are not yet broadly available. They are not for everyone, and every protocol has specific eligibility criteria that have to be met before a patient can enroll.
Enrollment is only recommended after a thorough diagnosis and review of the available standard options. If a trial is a reasonable fit, the team walks through the protocol, the schedule, the potential benefits, and the risks in detail before any decision is made.
The prostate sits next to the urethra and the neurovascular bundle, so whole-gland treatment can disrupt urinary, bowel, and sexual function. We are evaluating targeted photothermal therapy using gold-silica nanoparticles that absorb near-infrared light. The goal is a highly localized ultra-focal ablation of cancer with a substantially lower risk of leakage and erectile dysfunction.
About focal therapy →A better way to detect and quantify prostate cancer. We use modern MR imaging and fusion biopsy technology to target high-risk areas within the prostate and avoid missing clinically significant disease. In patients with a suspicious MRI, the cancer detection rate is roughly twice that of a standard TRUS biopsy.
About MRI-fusion biopsy →Specific eligibility criteria vary by trial and are reviewed at the screening visit.
Ready to talk?
Schedule a consultation to review your imaging, lab work, and treatment options.
